logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Scedosporiosis

    FiltersReset Filters
    8 results

    • vfend

      (voriconazole)
      Roerig
      Usage: VFEND is indicated for treating invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, and serious fungal infections caused by Scedosporium and Fusarium species in patients aged 2 years and older. Testing for causative organisms should precede therapy, but treatment may begin before results are available.

    • vfend

      (Voriconazole)
      Roerig
      Usage: VFEND is indicated for treating invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, and serious fungal infections caused by Scedosporium and Fusarium species in adults and pediatric patients (2 years and older) intolerant to or refractory to other therapies.

    • voriconazole

      (voriconazole)
      Sandoz Inc
      Usage: Voriconazole tablets are indicated for treating invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, and serious fungal infections caused by Scedosporium and Fusarium species in patients aged 2 years and older. Fungal cultures should guide therapy adjustments post-initiation.

    • voriconazole

      (voriconazole)
      Zydus Lifesciences Limited
      Usage: Voriconazole tablets are indicated for treating invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, and serious infections caused by Scedosporium and Fusarium species in patients aged 2 years and older. Initial therapy may begin before laboratory results are available, but should be adjusted based on findings.

    • voriconazole

      (voriconazole)
      Viona Pharmaceuticals Inc
      Usage: Voriconazole tablets are indicated for treating invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, and serious fungal infections caused by Scedosporium and Fusarium species in patients aged 2 years and older, particularly those intolerant or refractory to other therapies.

    • voriconazole

      (Voriconazole)
      Greenstone LLC
      Usage: Voriconazole is indicated for treating invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, and serious fungal infections caused by Scedosporium apiospermum and Fusarium spp. in patients 2 years and older who are intolerant or refractory to other therapies.

    • voriconazole

      (voriconazole)
      Slate Run Pharmaceuticals
      Usage: Voriconazole for injection is indicated for adults and pediatric patients (2 years and older) to treat invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, and serious fungal infections caused by Scedosporium apiospermum and Fusarium species, especially when other therapies are ineffective or intolerable.

    • voriconazole

      (Voriconazole)
      Eugia US LLC
      Usage: Voriconazole for injection is indicated for treating invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, and serious fungal infections caused by Scedosporium and Fusarium species in patients intolerant to or refractory to other therapies. Suitable for adults and pediatric patients aged 2 years and older.